{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-064427","form_type":"8-K","ticker":"ZURA","cik":"0001855644","company_name":"Zura Bio Ltd","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.392864+00:00","generated_at":"2026-05-18T10:30:59.433650+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Zura Bio appoints Eric Hyllengren as CFO; Verender Badial steps down effective July 7, 2025","bullets":["Eric Hyllengren appointed CFO effective July 7, 2025; previously COO/CFO at Atara Biotherapeutics and 15 years at Amgen.","Verender Badial resigns as CFO, stays as non-executive employee through July 31, 2025 to assist transition.","Badial receives £178,294.92 cash severance, accelerated vesting for 186,561 options; 303,100 options forfeited.","Hyllengren gets $475,000 base salary, 40% target bonus, and option for 672,000 shares vesting over 4 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-064427","json":"https://secwatch.observer/filing/0001104659-25-064427.json","markdown":"https://secwatch.observer/filing/0001104659-25-064427.md","text":"https://secwatch.observer/filing/0001104659-25-064427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925064427/0001104659-25-064427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855644/000110465925064427/tm2519325d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T10:30:59.433650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}